Global Expansion Allurion's international expansion, including the India launch and a distribution partnership with Minogue Medical, highlights a clear path for channel sales teams to recruit distributors and pursue multi-country deals with regulatory and service support.

Digital Health Growth The AI powered GLP one programme signals upsell opportunities for digital health offerings, remote patient monitoring, and data analytics that can be sold to clinics seeking enhanced patient engagement and outcomes.

Innovative Device Portfolio The swallowable gastric balloon platform demonstrates a non-surgical obesity treatment option with a track record and ongoing clinical data suitable for hospital systems and ambulatory clinics pursuing innovative therapies and reimbursement conversations.

Financial Momentum A substantial revenue base and growing international footprint provide scale advantages for large customers like multi-site health systems seeking proven obesity care solutions with predictable outcomes and ROI.

Clinical Engagement Regular clinician outreach through major obesity and metabolic conferences creates opportunities to partner on education, case studies, and co-branded programs to accelerate adoption and contract expansion.